Back to Browse Journals » Clinical Ophthalmology » Volume 5

Prospective, randomized, fellow eye comparison of WaveLight® Allegretto Wave® Eye-Q versus VISX CustomVueTM STAR S4 IRTM in photorefractive keratectomy: analysis of visual outcomes and higher-order aberrations

Authors Moshirfar M, Churgin DS, Betts BS, Hsu M, Sikder S, Neuffer M, Church D, Mifflin MD

Published Date August 2011 Volume 2011:5 Pages 1185—1193

DOI http://dx.doi.org/10.2147/OPTH.S24319

Published 22 August 2011

Majid Moshirfar1, Daniel S Churgin2, Brent S Betts3, Maylon Hsu1, Shameema Sikder4, Marcus Neuffer1, Dane Church5, Mark D Mifflin1
1University of Utah, John A Moran Eye Center, Department of Ophthalmology and Visual Sciences, Salt Lake City, UT, USA; 2University of Arizona College of Medicine, Phoenix, AZ; 3Temple University School of Medicine, Philadelphia, PA, USA; 4Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA; 5Virginia Commonwealth University School of Medicine, Richmond, VA, USA

Background: The purpose of this study was to compare differences in visual outcomes, higher-order aberrations, contrast sensitivity, and dry eye in patients undergoing photorefractive keratectomy using wavefront-guided VISX CustomVue™ and wavefront-optimized WaveLight® Allegretto platforms.
Methods: In this randomized, prospective, single-masked, fellow-eye study, photorefractive keratectomy was performed on 46 eyes from 23 patients, with one eye randomized to WaveLight Allegretto, and the fellow eye receiving VISX CustomVue. Three-month postoperative outcome measures included uncorrected distance visual acuity, corrected distance visual acuity, refractive error, root mean square of total and grouped higher-order aberrations, contrast sensitivity, and Schirmer’s testing.
Results: Mean values for uncorrected distance visual acuity (logMAR) were —0.03 ± 0.07 and —0.06 ± 0.09 in the wavefront-optimized and wavefront-guided groups, respectively (P = 0.121). Uncorrected distance visual acuity of 20/20 or better was achieved in 91% of eyes receiving wavefront-guided photorefractive keratectomy, and 87% of eyes receiving wavefront-optimized photorefractive keratectomy, whereas uncorrected distance visual acuity of 20/15 was achieved in 35% of the wavefront-optimized group and 64% of the wavefront-guided group (P ≥ 0.296). While root mean square of total higher-order aberration, coma, and trefoil tended to increase in the wavefront-optimized group (P = 0.091, P = 0.115, P = 0.459, respectively), only spherical aberration increased significantly (P = 0.014). Similar increases were found in wavefront-guided root mean square of total higher-order aberration (P = 0.113), coma (P = 0.403), trefoil (P = 0.603), and spherical aberration (P = 0.014). There was no significant difference in spherical aberration change when comparing the two platforms. The wavefront-guided group showed an increase in contrast sensitivity at 12 cycles per degree (P = 0.013).
Conclusion: Both VISX CustomVue and WaveLight Allegretto platforms performed equally in terms of visual acuity, safety, and predictability in photorefractive keratectomy. The wavefront-guided group showed slightly improved contrast sensitivity. Both lasers induced a comparable degree of statistically significant spherical aberration, and tended to increase other higher-order aberration measures as well.

Keywords: wavefront-guided, wavefront-optimized, photorefractive keratectomy


Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other articles by this author:

Accuracy of corneal trephination depth using the Moria single-use adjustable depth vacuum trephine system

Fenzl CR, Gess AJ, Moshirfar M

Clinical Ophthalmology 2014, 8:2391-2396

Published Date: 27 November 2014

What we know about ocular manifestations of Ebola

Moshirfar M, Fenzl CR, Li Z

Clinical Ophthalmology 2014, 8:2355-2357

Published Date: 21 November 2014

Rate of ectasia and incidence of irregular topography in patients with unidentified preoperative risk factors undergoing femtosecond laser-assisted LASIK

Moshirfar M, Smedley JG, Muthappan V, Jarsted A, Ostler EM

Clinical Ophthalmology 2014, 8:35-42

Published Date: 10 December 2013

Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature

Simpson RG, Moshirfar M, Edmonds JN, Christiansen SM, Behunin N

Clinical Ophthalmology 2012, 6:1827-1837

Published Date: 5 November 2012

Anesthetic keratopathy presenting as bilateral Mooren-like ulcers

Khakshoor H, Moshirfar M, Simpson RG, Gharaee H, Vejdani AH, Christiansen SM, Edmonds JN, Behunin NL

Clinical Ophthalmology 2012, 6:1719-1722

Published Date: 26 October 2012

Laser in-situ keratomileusis in patients with diabetes mellitus: a review of the literature

Simpson RG, Moshirfar M, Edmonds JN, Christiansen SM

Clinical Ophthalmology 2012, 6:1665-1674

Published Date: 12 October 2012

The effect of preoperative keratometry on visual outcomes after moderate myopic LASIK

Christiansen SM, Neuffer MC, Sikder S, Semnani RT, Moshirfar M

Clinical Ophthalmology 2012, 6:459-464

Published Date: 21 March 2012

Radial keratotomy associated endothelial degeneration

Moshirfar M, Ollerton A, Semnani RT, Hsu M

Clinical Ophthalmology 2012, 6:213-218

Published Date: 2 February 2012

A Comparison of the American Society of Cataract and Refractive Surgery post-myopic LASIK/PRK Intraocular Lens (IOL) calculator and the Ocular MD IOL calculator

DeMill DL, Moshirfar M, Neuffer MC, Hsu M, Sikder S

Clinical Ophthalmology 2011, 5:1409-1414

Published Date: 27 September 2011

A prospective, randomized, fellow eye comparison of WaveLight® Allegretto Wave® Eye-Q versus VISX CustomVue™ STAR S4 IR™ in laser in situ keratomileusis (LASIK): analysis of visual outcomes and higher order aberrations

Moshirfar M, Betts BS, Churgin DS, Hsu M, Neuffer M, Sikder S, Church D, Mifflin MD

Clinical Ophthalmology 2011, 5:1339-1347

Published Date: 20 September 2011

Evaluation of the American Society of Cataract and Refractive Surgery intraocular lens calculator for eyes with prior radial keratotomy

DeMill DL, Hsu M, Moshirfar M

Clinical Ophthalmology 2011, 5:1243-1247

Published Date: 31 August 2011

Bilateral total Descemet's membrane detachments after strangulation

Moshirfar M, Betts BS, Hsu M, Holz HHA, McEntire W

Clinical Ophthalmology 2011, 5:1221-1222

Published Date: 29 August 2011

In vivo and in vitro analysis of topographic changes secondary to DSAEK venting incisions

Moshirfar M, Lependu MT, Church D, Neuffer MC

Clinical Ophthalmology 2011, 5:1195-1199

Published Date: 25 August 2011

Comparison of Hanna and Hessburg-Barron trephine and punch systems using histological, anterior segment optical coherence tomography, and elliptical curve fitting models

Moshirfar M, Calvo CM, Kinard KI, Williams LB, Sikder S, Neuffer MC

Clinical Ophthalmology 2011, 5:1121-1125

Published Date: 12 August 2011

Femtosecond-assisted preparation of donor tissue for Boston type 1 keratoprosthesis

Moshirfar M, Neuffer MC, Kinard K, Lependu MT, Sikder S

Clinical Ophthalmology 2011, 5:1017-1020

Published Date: 22 July 2011

A prospective, contralateral comparison of photorefractive keratectomy (PRK) versus thin-flap LASIK: assessment of visual function

Hatch BB, Moshirfar M, Ollerton AJ, Sikder S, Mifflin MD

Clinical Ophthalmology 2011, 5:451-457

Published Date: 21 April 2011

Complications of NewColorIris implantation in phakic eyes: a review

Sikder S, Davis SW, Holz H, Moshirfar M

Clinical Ophthalmology 2011, 5:435-438

Published Date: 5 April 2011

Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision

Espandar L, Sikder S, Moshirfar M

Clinical Ophthalmology 2011, 5:159-160

Published Date: 6 February 2011

Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision

Ladan Espandar, Shameema Sikder, Majid Moshirfar

Clinical Ophthalmology 2011, 5:65-70

Published Date: 10 January 2011

Epithelial growth over the optic surface of the type 1 Boston Keratoprosthesis: histopathology and implications for biointegration

Yousuf M Khalifa, Don Davis, Nick Mamalis, et al

Clinical Ophthalmology 2010, 4:1069-1071

Published Date: 17 September 2010

Readers of this article also read:

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Population pharmacokinetics of olprinone in healthy male volunteers

Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H

Clinical Pharmacology: Advances and Applications 2014, 6:43-50

Published Date: 4 March 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Clinical Pharmacology: Advances and Applications 2011, 3:27-37

Published Date: 18 August 2011

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010